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Implication for health policy/practice/research/medical education:
Butea frondosa aqueous leaves extracts are capable of enhancing both antibody and cell mediated immune responses against 
hepatitis B surface antigen (HBsAg) in mice. Furthermore, they expressed a lower haemolytic effect and might be safely used as 
an adjuvant.
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Introduction: Immunological adjuvants derived from various synthetic micro-organisms or 
from medicinal plant products enhance specific immune responses against vaccine antigens. 
Immunological studies have already done pertaining to identify compounds from medicinal plant 
metabolites that are suitable for vaccine formulation. In this study, aqueous leave extracts of Butea 
frondosa were selected to evaluate their haemolytic activity and immunoadjuvant effects.
Methods: For this study, immunoadjuvant activity was investigated ex vivo in mice model based 
studies using splenocyte proliferation assay and also measured IgG titre in cell culture supernatant 
(using indirect ELISA). Swiss mice were immunized subcutaneously with specific protein antigen 
i.e. hepatitis B vaccine containing surface antigen (HBsAg, 20 µg/mL; 10 µl) on day 0 and collected 
the spleen cells on day 4 and proceeded for proliferation assay of variable doses of aqueous leaves 
extracts of Butea frondosa (0.5–30 mg/ml; 50 µl) along with hepatitis B surface antigen (HBsAg) 
(challenging dose; 20 µg/mL; 10 µl) and also estimated the antibody (IgG) titre in splenocyte cell 
culture supernatant including determination of its haemolytic activity in human whole blood 
samples. 
Results: The results demonstrated that aqueous leave extracts stimulated HBsAg population at lower 
doses (0.5 mg/mL) and also enhanced IgG titre as compared with control and HBsAg treated group. 
In addition, aqueous leaves extracts of Butea frondosa showed anti-HBsAg titre at higher doses and 
also showed slightly haemolytic effect in human whole blood. 
Conclusion: These results suggested that aqueous extract of Butea frondosa may represent viable 
candidate for effective vaccine adjuvants due to their higher immune response (with respect to IgG 
titre and proliferation assay) and lower or non-haemolytic effects.
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Introduction
Medicinal plants are normally used as raw material for 
separating the active ingredients which are generally used 
for the synthesis of compounds (simple or complex). In 
contrast, these medicinal plant products (stem, root, 
leaves, flowers, etc.) showed many immunopharmaco-
logical properties e.g. anti-arthritic, anti-inflammatory, 
adjuvant, immunomodulation, anti-tumor, etc (1-5). Lots 
of research works have already been done related to those 
medicinal plant products which proved that metabolites 
(primary or secondary) have their ability to prevent the 
appearance or burden of some diseases e.g. glycosides 
from Picrorhiza kurroa (6), polysaccharides (7) fraction 
from Boswellia serrata, aqueous extract of Azadirachta 
indica, etc (8). These medicinal plants have their ability 
to reduce the burden of disease and used as adjuvants for 
vaccine antigen.
Adjuvants have been used in vaccines for many years 
pertaining to increase the immunogenicity of vaccine 
antigen. Only one adjuvant approved for human use i.e. 
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alum which increased only humoral response and poorly 
elicited cell mediated immunity (9). Recently, synthetic 
formulation or plant derived adjuvants (e.g. oil in water 
emulsion, water in oil emulsion, liposomes, cytokines, 
lipid A, bacterial toxins, carbohydrate polymers and sapo-
nins) have been categorized into two major subtypes i.e. 
particulate and non-particulate (9). Thus, immunological 
efforts have been made pertaining to identify the ideal ad-
juvant for vaccine antigen (9,10). As per the literature, me-
tabolites (primary or secondary) extracted from various 
medicinal plants showed some adjuvant effects against s 
vaccine antigens. For example, saponins showed highly 
cytotoxic effects and induced both Th1 and Th2 type of 
immune response (2-4). Thus, researchers focused only 
on those medicinal plant metabolites with high immune 
activity with respect to antibody and cell mediated im-
mune response with low haemolytic effect.
Among medicinal plants, Butea frondosa (commonly 
known as palas; family Fabaceae), grows all over India 
especially central and western India (11,12). As per the 
literature, seeds, flowers, leaves, bark etc. have great me-
dicinal value and showed various medicinal properties 
or uses (11,12). In addition, these medicinal plant parts 
including leaves have shown anti-inflammatory as well as 
anti-microbial activities, as well. In this study, our group 
focused on Butea frondosa in order to analyse its haemo-
lytic activity on red blood cells and compared their immu-
nobiological effect to those adjuvants e.g. alum which are 
commonly used in animal and human vaccination. 
Materials and methods
Plant material and phytochemical investigation
Fresh healthy plant leaves of Butea frondosa were collected 
from Vidya Pratishthan’s School of Biotechnology garden 
during the month of January 2016. The plant materials 
were dried in a shady area and prepared in finely pow-
dered form. For phytochemical investigation, three grams 
of leaves powder (Butea frondosa) were macerated in liq-
uid nitrogen with mortar and pestle and then dissolved 
in phosphate buffered saline (PBS) (pH 7.2; 30 mL). The 
aqueous extracts were filtered and used to determine the 
presence of secondary metabolites. The phytochemical in-
vestigation of the aqueous extracts was carried out as per 
standard methods and evaluated for the presence of phe-
nolic compounds, flavonoids (by alkaline reagent test), sa-
ponin (by foam test), terpenoids (by acetic anhydride test) 
and glycosides. In addition, thin layer chromatography of 
the aqueous extract was performed using n butanol: acetic 
acid: water (5:3:2). The observed spots were then visual-
ized using anisaldehyde-sulphuric acid reagent (11).
Immunization
Swiss mice (n = 5) were immunized subcutaneously on day 
0 with HBsAg (10 µg) in a final volume of 0.2 mL contain-
ing PBS. For this study, PBS was used as negative control. 
Splenocyte proliferation assay (ex-vivo)
Splenocyte proliferation was done as per the guidelines of 
animal ethics committee, CPCSEA. On day 7, Swiss mice 
were sacrificed by cervical dislocation and the splenocytes 
were seeded in triplicates at a concentration of 106 cells/
mL, 0.1 mL along with variable concentration of aqueous 
leaves extract of Butea frondosa (0.5-30 mg/mL; 50 µl) in 
flat bottom tissue culture 96 well plate in a final volume 
of 0.2 mL. hepatitis B surface antigen (HBsAg) (Serum 
Institute of India; 20 μg/mL; 10 µl) was added to all the 
wells with or without aqueous extract in a volume of 0.2 
mL. After the addition, the samples were incubated for 48 
hours at carbon dioxide incubator and then supernatant 
were collected after centrifugation for IgG titre. After add-
ing fresh medium in 96-well plate, the plate was incubated 
for another 2 hours. After incubation, MTT solution (2.5 
mg/mL; 10 µl) was added. These samples were incubat-
ed for another 3 hours at carbon dioxide incubator and 
then the formazan crystals were observed and dissolved 
in dimethyl sulphoxide (DMSO). Finally, optical densities 
(ODs) of each well were evaluated using an ELISA reader 
at 570 nm (10,11).
ELISA performance
Indirect ELISA was performed using hepatitis B vaccine 
(HBsAg; 2 µg/mL) as coating antigen. Aqueous leaves ex-
tracts of Butea frondosa were prepared and the culture su-
pernatants were collected after 48 hours from splenocyte 
proliferation assay for the estimation of IgG antibody titre. 
Horse anti-mouse serum was used as secondary antibody, 
and the OD was measured at 450 nm (8).
Haemolytic activity assay
The haemolytic activity in human whole blood was de-
termined using aqueous extract of Butea frondosa. Dis-
tilled water was used as positive control for the study. In 
this study, human whole blood suspension was collected 
from Mangal Pathology Laboratory, Baramati, and these 
samples were prepared by diluting the pellet to 0.5% with 
PBS along with variable concentrations of aqueous leaves 
extracts of Butea frondosa. The samples were incubated 
for 2 hours at carbon dioxide incubator. After incubation, 
the samples were centrifuged and the supernatants were 
collect and estimated the free haemoglobin in the super-
natants using spectrophotometer. The OD was measured 
at 405 nm (13). 
Statistical analysis
The difference between control and treated groups of 
Butea frondosa was determined by one-way analysis of 
variance (ANOVA) test (Bonferroni multiple comparison 
test). Values were expressed as mean ± standard error of 
mean (SE).
Results
Splenocyte proliferation assay
The effects of variable doses of aqueous leaves extracts of 
Butea frondosa on splenocyte proliferation assay in mice 
model are shown in Figure 1. The results showed that 
there was enhancement in proliferation with respect to 
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HBsAg using aqueous leaves extracts at lower doses. HB-
sAg was used as standard and there was enhancement in 
proliferation as compared to control.
ELISA results
The effects of variable doses of aqueous leaves extracts on 
IgG antibody titre are as shown in Figure 2. The aqueous 
leaves extract showed IgG antibody titre at higher doses 
whereas cell culture supernatant of spleen cells collected 
after 48 hours showed enhancement of IgG antibody titre 
at lower doses as compared to control.
Haemolytic activity
The effects of variable doses of aqueous leaves extracts of 
Butea frondosa on haemolytic activity are shown in Figure 
3. The aqueous leaves extract did not show any haemolytic 
activity at higher doses whereas distilled water was used 
as positive control and showed high haemolytic activity as 
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Figure 1. Splenocyte proliferation assay (ex vivo). Spleno-
cytes of Swiss mice were prepared on day 4 after immunization 
with HBsAg, 10 µg on day 0 and cultured with HBsAg or together 
with variable concentration of aqueous leaves extract (0.5–30 mg/
ml; 50 μl) for 48 hours. Splenocyte proliferation was measured 
using MTT assay as described in materials and methods section. 
The values are presented as the mean ± SE (n = 6). Significant 
differences with control groups (samples blank) were designated 
as *P < 0.05 and **P < 0.01.
Figure 2. Indirect ELISA (IgG titre). Indirect Elisa was performed 
using standard HBsAg (1:1000 dilution) vaccine as coating 
antigen. For IgG titre, aqueous leaves extract of Butea frondosa 
were prepared and also collect the splenocyte cell culture 
supernatant were used for the estimation of anti-HBsAg antibody 
titre. Horse anti-serum used as secondary antibody and optical 
density measured at 450 nm. The values are presented as the 
mean ± SE (n = 6). Significant differences with control groups 
(samples blank) were designated as *P < 0.05 and **P < 0.01.
Figure 3. Haemolytic activity. Human whole blood samples 
were prepared by diluting the pellet in PBS along with variable 
concentration of aqueous leaves extract of Butea frondosa. 
Haemolytic percentages of PBS and distilled water were included 
as minimal and maximal haemolytic controls. All values represent 
the mean ± SE (n = 6). The optical density (OD) was measured 
at 405 nm.
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compared to control.
Discussion
Immunomodulation means to modulate the immune 
system either stimulatory or suppressive showed some 
adjuvant effects against specific (e.g. protein) as well as 
non-specific (e.g. sheep red blood corpuscles; sub-im-
munogenic dose) antigens (14). For many years, immu-
nopharmacologists have focused on various medicinal 
plant products in order to carry out their various immu-
nobiological activities e.g. anti-viral, anti-bacteria, anti-
inflammatory with respect to antibody and cell mediated 
immune response (2-5). According to the literature, lots 
of research works has already been done with respect to 
medicinal plants that are responsible for curing immuno-
logical disorders. In addition, these medicinal plants also 
played a vital role in the promotion of health by strength-
ening host defence mechanisms against various diseases 
(10,11). In order to achieve this objective, our group fo-
cused on its haemolytic as well as immunoadjuvant activ-
ity of aqueous leaves extract of Butea frondosa.
In Asian countries especially India, people believe on vari-
ous medicinal plants including Butea frondosa that have 
been used in traditional system of medicine for several 
thousand years and these plants constituted to be an im-
portant and basic resource for ethnobotanical research in 
many ways. In the present study, our group focused on 
immunoadjuvant activity of Butea frondosa using HB-
sAg as specific protein antigen pertaining to determined 
its T cell-mediated immunity (i.e. complex interactions 
between the lymphoid and phagocytic cells) that played 
an important role in eliminating intracellular infections 
and was responsible for enhancing the lymphocyte pro-
liferative response (10,11). In this study, HBsAg was used 
as standard for the study and enhanced the lymphocyte 
proliferation as compared to control. As shown in Figure 
1. Our data showed that aqueous leaves extract of Butea 
frondosa at lower doses enhanced proliferative response as 
compared to HBsAg and control. Overall, the data showed 
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that the aqueous leaves extract could significantly enhance 
the T cell response i.e. cell mediated immunity.
The results also showed that aqueous leaves extracts 
caused enhancement in antibody titre at higher doses 
whereas splenocyte cell culture supernatant showed some 
enhancement at lower doses as compared to control. HB-
sAg containing alum was used as standard for the study 
and enhanced the production of IgG titre as compared 
to control. Overall this study claimed that aqueous leaves 
extract of Butea frondosa were effective on antibody and 
cell mediated immune response with respect to IgG titre 
and lymphocyte proliferative response using HBsAg con-
taining alum. In addition, aqueous leaves extracts showed 
slightly haemolytic effect as compared to control. In short, 
ex vivo experimental results indicated the adjuvant activ-
ity of Butea frondosa against specific antigen i.e. HBsAg.
Conclusion
Butea frondosa, aqueous leaves extract are capable of 
enhancing both antibody and cell mediated immune re-
sponses against HBsAg in mice. Furthermore, they ex-
pressed a lower haemolytic effect and could be safely used 
as an adjuvant. 
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